caffeine has been researched along with n-methyl-3,4-methylenedioxyamphetamine in 38 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (2.63) | 18.2507 |
| 2000's | 9 (23.68) | 29.6817 |
| 2010's | 26 (68.42) | 24.3611 |
| 2020's | 2 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Callaway, CW; Geyer, MA; Rempel, NL | 1 |
| Harkin, A; Kerans, A; McNamara, R; O'Neill, B | 1 |
| Commandeur, JN; Damsten, MC; Maasdijk, DM; van Vugt-Lussenburg, BM; Vermeulen, NP | 1 |
| Camarasa, J; Escubedo, E; Pubill, D | 1 |
| Harkin, A; Maginn, M; McNamara, R | 1 |
| Inoue, H; Iwata, Y; Kamo, N; Kanamori, T; Kishi, T; Kuwayama, K; Miyaguchi, H; Miyauchi, S; Tsujikawa, K | 1 |
| Bello, PY; Giraudon, I | 1 |
| Inoue, H; Iwata, YT; Kanamori, T; Kuwayama, K; Miyaguchi, H; Tsujikawa, K; Yoshida, T | 1 |
| Araújo, JR; Gonçalves, P; Martel, F | 1 |
| Araújo, JR; Gonçalves, P; Martel, F; Pinho, MJ | 1 |
| Frau, L; Khairnar, A; Morelli, M; Plumitallo, A; Schintu, N | 1 |
| Harkin, A; McNamara, R; Vanattou-Saïfoudine, N | 3 |
| Chen, J; He, M; Hu, B; Xiong, J | 1 |
| Gossen, A; Harkin, A; Vanattou-Saïfoudine, N | 1 |
| Fuchigami, Y; Igari, Y; Ikeda, R; Kuroda, N; Nakashima, K; Wada, M | 1 |
| Ben Hamida, S; Cassel, JC; de Vasconcelos, AP; Jones, BC; Mohamed, WM | 1 |
| Behan, B; Harkin, A; Vanattou-Saïfoudine, N | 1 |
| Carbó, ML; de la Torre, R; Farre, M; Langohr, K; Mathuna, BÓ; Mustata, C; Pardo, R; Perez-Mañá, C; Torrens, M; Yubero-Lahoz, S | 1 |
| Hawryluck, LA; Kraeva, N; Riazi, S; Russell, T; Steel, AC | 1 |
| Miñarro, J; Pinto-Xavier, A; Rodríguez-Arias, M; Ruiz-Medina, J; Valverde, O | 1 |
| Clemons, K; Dziekonski, E; Fox, J; Verbeck, GF; Waverka, K; Wiley, R | 1 |
| Daly, F; Downey, C; O'Boyle, KM | 1 |
| Fang, MD; Jiang, JJ; Lee, CL | 1 |
| Górska, AM; Gołembiowska, K; Noworyta-Sokołowska, K | 1 |
| Górska, AM; Gołembiowska, K | 1 |
| Castelli, MP; Costa, G; Ennas, MG; Frau, L; Khairnar, A; Madeddu, C; Morelli, M; Porceddu, PF; Wardas, J | 1 |
| Fone, KC; Green, AR; King, MV; Shortall, SE | 1 |
| Bade, R; Baz-Lomba, JA; Bramness, J; Castiglioni, S; Castrignanò, E; Causanilles, A; de Voogt, P; Gracia-Lor, E; Hernandez, F; Kasprzyk-Hordern, B; Kinyua, J; McCall, AK; Ort, C; Plósz, BG; Ramin, P; Reid, M; Rousis, NI; Ryu, Y; Salvatore, S; Thomas, K; van Nuijs, A | 1 |
| Berretta, P; Busardò, FP; Gentili, S; Gregori, A; Pacifici, R; Pichini, S | 1 |
| Campen, KA; McNatty, KP; Pitman, JL | 1 |
| Cadoni, C; Corongiu, S; Dessì, C; Di Chiara, G; Frau, L; Pisanu, A; Plumitallo, A; Porceddu, PF; Sil, A; Simola, N; Wardas, J | 1 |
| Lowry, JP; O'Boyle, KM; O'Connor, JJ | 1 |
| Costa, G; Górska, AM; Gołembiowska, K; Kamińska, K; Kreiner, G; Morelli, M; Przewłocki, R; Wawrzczak-Bargieła, A | 1 |
| Edwards, QA; Garner-O'Neale, LD; Kulikov, SM; Metcalfe, CD; Sultana, T; Yargeau, V | 1 |
| Harvey, BK; Trychta, KA | 1 |
| Bastiani, MF; da Silva Moreira, IC; do Nascimento, CA; Hahn, RZ; Linden, R; Lizot, LLF; Meireles, YF; Schneider, A; Viana, MF | 1 |
2 review(s) available for caffeine and n-methyl-3,4-methylenedioxyamphetamine
| Article | Year |
|---|---|
MDMA: interactions with other psychoactive drugs.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Caffeine; Cannabis; Central Nervous System Depressants; Cocaine; Drug Interactions; Ethanol; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Nicotine; Psychotropic Drugs; Substance-Related Disorders | 2011 |
Caffeine provokes adverse interactions with 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') and related psychostimulants: mechanisms and mediators.
Topics: Animals; Caffeine; Central Nervous System Stimulants; Drug Interactions; Hallucinogens; Humans; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamine | 2012 |
36 other study(ies) available for caffeine and n-methyl-3,4-methylenedioxyamphetamine
| Article | Year |
|---|---|
Serotonin1B receptor activation mimics behavioral effects of presynaptic serotonin release.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Behavior, Animal; Caffeine; Designer Drugs; Dopamine Agents; Dose-Response Relationship, Drug; Fluoxetine; Indoles; Male; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Nicotine; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Scopolamine; Serotonin; Serotonin Receptor Agonists; Synapses | 1993 |
Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
Topics: 3,4-Methylenedioxyamphetamine; Animals; Area Under Curve; Behavior, Animal; Body Temperature; Brain Chemistry; Caffeine; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Drug Synergism; Drug Tolerance; Fever; Hallucinogens; Hydroxyindoleacetic Acid; Male; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Seizures; Serotonin | 2006 |
Heterotropic and homotropic cooperativity by a drug-metabolising mutant of cytochrome P450 BM3.
Topics: Acetaminophen; Amodiaquine; Arginine; Benzoflavones; Caffeine; Cytochrome P-450 Enzyme System; Dextromethorphan; Enzyme Activation; Humans; Kinetics; Leucine; Molecular Structure; Mutation; N-Methyl-3,4-methylenedioxyamphetamine; Pharmaceutical Preparations; Phenylalanine; Substrate Specificity | 2006 |
Association of caffeine to MDMA does not increase antinociception but potentiates adverse effects of this recreational drug.
Topics: Analgesics; Animals; Body Temperature; Brain; Caffeine; Central Nervous System Stimulants; Disease Models, Animal; Down-Regulation; Drug Interactions; Fever; Hallucinogens; Male; Mice; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxins; Pain; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Serotonin; Serotonin; Serotonin Plasma Membrane Transport Proteins | 2006 |
Caffeine induces a profound and persistent tachycardia in response to MDMA ("Ecstasy") administration.
Topics: Animals; Caffeine; Central Nervous System Stimulants; Drug Synergism; Hallucinogens; Male; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Serotonin Agents; Tachycardia | 2007 |
Interactions between 3,4-methylenedioxymethamphetamine, methamphetamine, ketamine, and caffeine in human intestinal Caco-2 cells and in oral administration to rats.
Topics: Administration, Oral; Anesthetics, Dissociative; Animals; Area Under Curve; Caco-2 Cells; Caffeine; Cells, Cultured; Central Nervous System Stimulants; Drug Interactions; Forensic Toxicology; Hallucinogens; Humans; Intestinal Absorption; Intestinal Mucosa; Ketamine; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Wistar | 2007 |
Monitoring ecstasy content in France: results from the National Surveillance System 1999-2004.
Topics: Caffeine; Drug and Narcotic Control; Emigration and Immigration; France; Hallucinogens; Humans; Illicit Drugs; Law Enforcement; N-Methyl-3,4-methylenedioxyamphetamine; Police; Social Work; Substance-Related Disorders; Surveys and Questionnaires; Tablets | 2007 |
Development of an on-site screening system for amphetamine-type stimulant tablets with a portable attenuated total reflection Fourier transform infrared spectrometer.
Topics: 3,4-Methylenedioxyamphetamine; Algorithms; Amphetamines; Caffeine; Chemistry, Pharmaceutical; Drug Evaluation, Preclinical; Equipment Design; Ketamine; Lactose; N-Methyl-3,4-methylenedioxyamphetamine; Software; Spectroscopy, Fourier Transform Infrared; Substance Abuse Detection; Tablets | 2008 |
Modulation of glucose uptake in a human choriocarcinoma cell line (BeWo) by dietary bioactive compounds and drugs of abuse.
Topics: Acetaldehyde; Amphetamine; Biological Transport; Caffeine; Cell Line, Tumor; Cell Survival; Choriocarcinoma; Cytochalasin B; Deoxyglucose; Diet; Dronabinol; Ethanol; Flavonoids; Glucose; Humans; Illicit Drugs; Kinetics; N-Methyl-3,4-methylenedioxyamphetamine; Nicotine; Phenols; Polyphenols; Theophylline; Trophoblasts | 2008 |
Modulation of butyrate transport in Caco-2 cells.
Topics: 2,4-Dinitrophenol; 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid; 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Acetaldehyde; Acids, Acyclic; Aspirin; Biological Transport, Active; Butyrates; Caco-2 Cells; Caffeine; Cell Survival; Dronabinol; Gene Expression; Humans; Hydrogen-Ion Concentration; Indomethacin; Ions; Kinetics; Monocarboxylic Acid Transporters; N-Methyl-3,4-methylenedioxyamphetamine; Sodium Azide; Symporters; Theophylline | 2009 |
Caffeine enhances astroglia and microglia reactivity induced by 3,4-methylenedioxymethamphetamine ('ecstasy') in mouse brain.
Topics: Animals; Astrocytes; Brain; Caffeine; CD11b Antigen; Drug Interactions; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Male; Mice; Mice, Inbred C57BL; Microglia; N-Methyl-3,4-methylenedioxyamphetamine; Phosphodiesterase Inhibitors | 2010 |
Caffeine promotes dopamine D1 receptor-mediated body temperature, heart rate and behavioural responses to MDMA ('ecstasy').
Topics: Analysis of Variance; Animals; Behavior, Animal; Benzazepines; Body Weight; Caffeine; Central Nervous System Stimulants; Dopamine Agents; Drug Interactions; Hallucinogens; Heart Rate; Locomotion; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Sulpiride; Time Factors | 2010 |
Mechanisms mediating the ability of caffeine to influence MDMA ('Ecstasy')-induced hyperthermia in rats.
Topics: Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Animals; Body Temperature Regulation; Caffeine; Catecholamines; Dopamine Agents; Drug Interactions; Fever; Frontal Lobe; Hypothalamus; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Agents; Time Factors | 2010 |
Simultaneous quantification of amphetamines, caffeine and ketamine in urine by hollow fiber liquid phase microextraction combined with gas chromatography-flame ionization detector.
Topics: Amphetamines; Caffeine; Calibration; Chromatography, Gas; Drug Monitoring; Flame Ionization; Humans; Ketamine; Limit of Detection; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Reproducibility of Results; Substance-Related Disorders | 2010 |
A role for adenosine A(1) receptor blockade in the ability of caffeine to promote MDMA "Ecstasy"-induced striatal dopamine release.
Topics: Adenosine A1 Receptor Antagonists; Animals; Caffeine; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Hypothalamus; In Vitro Techniques; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neostriatum; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Xanthines | 2011 |
Pharmacodynamic interactions between MDMA and concomitants in MDMA tablets on extracellular dopamine and serotonin in the rat brain.
Topics: Animals; Brain; Caffeine; Dopamine; Drug Interactions; Extracellular Space; Ketamine; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Wistar; Serotonin; Tablets | 2011 |
Dopamine D1 receptor-mediated intracellular responses in the hypothalamus after co-administration of caffeine with MDMA.
Topics: Animals; Body Temperature; Caffeine; Cyclic AMP Response Element-Binding Protein; Dopamine and cAMP-Regulated Phosphoprotein 32; Drug Synergism; Gene Expression Regulation; Hypothalamus; Male; N-Methyl-3,4-methylenedioxyamphetamine; Phosphorylation; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Signal Transduction | 2012 |
Changes in CYP1A2 activity in humans after 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) administration using caffeine as a probe drug.
Topics: Adult; Area Under Curve; Caffeine; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Female; Half-Life; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Sex Factors; Theophylline | 2012 |
Ecstacy-induced delayed rhabdomyolysis and neuroleptic malignant syndrome in a patient with a novel variant in the ryanodine receptor type 1 gene.
Topics: Anesthetics, Inhalation; Antipsychotic Agents; Body Temperature; Caffeine; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Creatine Kinase; Dantrolene; Disseminated Intravascular Coagulation; Female; Genetic Variation; Hallucinogens; Haloperidol; Halothane; Humans; Multiple Organ Failure; N-Methyl-3,4-methylenedioxyamphetamine; Neuroleptic Malignant Syndrome; Recurrence; Rhabdomyolysis; Ryanodine Receptor Calcium Release Channel; Spectrum Analysis; Young Adult | 2012 |
Influence of chronic caffeine on MDMA-induced behavioral and neuroinflammatory response in mice.
Topics: Animals; Anxiety; Astrocytes; Behavior, Animal; Body Temperature; Caffeine; Central Nervous System Stimulants; Corpus Striatum; Dose-Response Relationship, Drug; Locomotion; Male; Mice; Microglia; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxicity Syndromes; Reflex; Time Factors | 2013 |
Direct analyte-probed nanoextraction coupled to nanospray ionization-mass spectrometry of drug residues from latent fingerprints.
Topics: Caffeine; Central Nervous System Stimulants; Cocaine; Dermatoglyphics; Heroin; Humans; Mass Spectrometry; Methamphetamine; Microscopy; N-Methyl-3,4-methylenedioxyamphetamine; Nanotechnology; Narcotics; Sebum; Spectrum Analysis, Raman; Sweat | 2013 |
An in vitro approach to assessing a potential drug interaction between MDMA (ecstasy) and caffeine.
Topics: Animals; Caffeine; Cell Line; Cell Survival; Central Nervous System Stimulants; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Hallucinogens; Humans; Isoenzymes; Kidney; L-Lactate Dehydrogenase; Liver; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Serotonin; Synaptosomes; Temperature | 2014 |
Emerging organic contaminants in coastal waters: anthropogenic impact, environmental release and ecological risk.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aquatic Organisms; Caffeine; Carbamazepine; Chromatography, Liquid; Environmental Monitoring; Gemfibrozil; Humans; Ketamine; N-Methyl-3,4-methylenedioxyamphetamine; Population Density; Pseudoephedrine; Risk; Rivers; Seawater; Solid Phase Extraction; Taiwan; Tandem Mass Spectrometry; Water Pollutants, Chemical | 2014 |
The effect of caffeine on MDMA-induced hydroxyl radical production in the mouse striatum.
Topics: Animals; Caffeine; Corpus Striatum; Dose-Response Relationship, Drug; Hydroxyl Radical; Male; Mice; N-Methyl-3,4-methylenedioxyamphetamine; Neuroprotective Agents; Neurotoxicity Syndromes | 2014 |
The role of adenosine A1 and A2A receptors in the caffeine effect on MDMA-induced DA and 5-HT release in the mouse striatum.
Topics: Adenosine A1 Receptor Antagonists; Animals; Caffeine; Dopamine; Male; Mice; Mice, Inbred C57BL; N-Methyl-3,4-methylenedioxyamphetamine; Neostriatum; Serotonin | 2015 |
Influence of caffeine on 3,4-methylenedioxymethamphetamine-induced dopaminergic neuron degeneration and neuroinflammation is age-dependent.
Topics: Age Factors; Aging; Animals; Caffeine; Dopaminergic Neurons; Drug Synergism; Inflammation; Male; Mice; Mice, Inbred C57BL; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Degeneration | 2016 |
Caffeine alters the behavioural and body temperature responses to mephedrone without causing long-term neurotoxicity in rats.
Topics: Animals; Behavior, Animal; Body Temperature; Brain; Caffeine; Discrimination, Psychological; Dopamine; Fever; Hypothermia; Illicit Drugs; Locomotion; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxicity Syndromes; Rats; Reflex, Startle; Serotonin | 2016 |
Comparison of pharmaceutical, illicit drug, alcohol, nicotine and caffeine levels in wastewater with sale, seizure and consumption data for 8 European cities.
Topics: Alcohol Drinking; Amphetamines; Beverages; Caffeine; Central Nervous System Stimulants; Cities; Cocaine; Commerce; Ethanol; Europe; Humans; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nicotiana; Nicotine; Pharmaceutical Preparations; Substance Abuse Detection; Substance-Related Disorders; Tobacco Use; Wastewater; Water Pollutants, Chemical | 2016 |
Purity and adulterant analysis of some recent drug seizures in Italy.
Topics: Caffeine; Central Nervous System Depressants; Chromatography, Gas; Cocaine; Dextromethorphan; Drug Contamination; Hallucinogens; Heroin; Illicit Drugs; Italy; N-Methyl-3,4-methylenedioxyamphetamine; Narcotics | 2017 |
A protective role of cumulus cells after short-term exposure of rat cumulus cell-oocyte complexes to lifestyle or environmental contaminants.
Topics: Animals; Benzhydryl Compounds; Caffeine; Cells, Cultured; Cumulus Cells; Dronabinol; Environmental Pollutants; Female; Gene Expression Regulation; Illicit Drugs; Life Style; N-Methyl-3,4-methylenedioxyamphetamine; Nicotine; Oocytes; Phenols; Rats, Sprague-Dawley | 2017 |
Widespread reduction of dopamine cell bodies and terminals in adult rats exposed to a low dose regimen of MDMA during adolescence.
Topics: Animals; Brain; Caffeine; Cell Body; Cell Count; Dopaminergic Neurons; Drug Interactions; Fluorescent Antibody Technique; Male; Memory Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Rats, Sprague-Dawley; Recognition, Psychology; Tyrosine 3-Monooxygenase | 2017 |
Effects of a combination of 3,4-methylenedioxymeth amphetamine and caffeine on real time stimulated dopamine release in the rat striatum: Studies using fast cyclic voltammetry.
Topics: Animals; Caffeine; Chemistry Techniques, Analytical; Corpus Striatum; Dopamine; Drug Interactions; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neurotransmitter Agents; Rats; Rats, Wistar | 2018 |
Neurochemical and Neurotoxic Effects of MDMA (Ecstasy) and Caffeine After Chronic Combined Administration in Mice.
Topics: Animals; Caffeine; Central Nervous System Stimulants; Comet Assay; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Enkephalins; Exploratory Behavior; Extracellular Fluid; Gene Expression Regulation; Hallucinogens; Locomotion; Male; Mice; Mice, Inbred C57BL; N-Methyl-3,4-methylenedioxyamphetamine; Protein Precursors; Recognition, Psychology; RNA-Binding Proteins; Serotonin | 2018 |
Contaminants of Emerging Concern in Wastewaters in Barbados, West Indies.
Topics: 3,4-Methylenedioxyamphetamine; Androstenedione; Barbados; Caffeine; Chromatography, Liquid; Cocaine; Environmental Monitoring; Estrone; Ibuprofen; N-Methyl-3,4-methylenedioxyamphetamine; Tandem Mass Spectrometry; Wastewater; Water Pollutants, Chemical | 2018 |
Caffeine and MDMA (Ecstasy) Exacerbate ER Stress Triggered by Hyperthermia.
Topics: Animals; Body Temperature; Caffeine; Cell Line; Cells, Cultured; Central Nervous System Stimulants; Endoplasmic Reticulum Stress; Female; Humans; Hyperthermia, Induced; Illicit Drugs; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Unfolded Protein Response | 2022 |
Long-term monitoring of drug consumption patterns during the COVID-19 pandemic in a small-sized community in Brazil through wastewater-based epidemiology.
Topics: Amphetamine; Brazil; Caffeine; Cocaine; COVID-19; Dronabinol; Humans; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamine; Nicotine; Pandemics; Substance Abuse Detection; Substance-Related Disorders; Wastewater; Wastewater-Based Epidemiological Monitoring; Water Pollutants, Chemical | 2022 |